Giant cell tumors (GCTs) most commonly occur near the ends of long bones, especially around the knee, with the distal femur (lower thigh bone) and proximal tibia (upper shin bone) being the most frequent locations, followed by the distal radius (wrist). They typically appear in the epiphyseal (end) region of bones in young adults.
A giant cell tumor is a rare, aggressive, noncancerous tumor. It often grows near a joint at the end of the bone. Most occur in the long bones of the legs and arms. They most often occur in adults between ages 20 and 40, when skeletal bone growth is complete.
Giant cell tumors are rare overall, affecting only 1.7 per 1 million people. Still, GCTs account for 15% to 21% of all benign tumors that start in your bones.
While giant cell tumors are typically benign (noncancerous), they can grow quickly and destroy bone close to a joint. In rare cases, a giant cell tumor may spread, or metastasize, to the lungs.
A giant cell tumor can be quite destructive locally, and has potential to break through the bone's outer layer (cortex), cause a fracture, known as a pathological fracture, and extend into the surrounding soft tissues. A giant cell tumor is considered benign, yet giant cell tumors can spread to the lungs.
Abstract. The giant cell tumor of bones (GCTB) is a benign bone tumor with high postoperative recurrence potential.
Giant cells are of many different types and occur under different conditions and assume different configurations. They are formed by fusion of macrophages and are common in granulomatous inflammation especially in infections such as tuberculo- sis, syphilis, and those produced by fungi.
Some common signs of metastatic cancer include:
In the girl, the tumor grew from 33 cm3 to 85 cm3 in 65 days, and in the man from 11 cm3 to 175 cm3 in 311 days before the lesions were diagnosed. The high rate of growth of these neoplasms reflects the inherent malignancy of giant-cell tumors around the knee.
The main treatment for giant cell arteritis consists of high doses of a corticosteroid drug such as prednisone. Because immediate treatment is necessary to prevent vision loss, your doctor is likely to start medication even before confirming the diagnosis with a biopsy.
Classification. GCT were classified by Enneking and later by Campanacci based on radiographic appearance. They described three stages that correlate with tumor local aggressiveness and risk of local recurrence, Stage I – latent, Stage II – active, Stage III – aggressive.
With early diagnosis and treatment, the outlook is good, and symptoms often start to improve within days. Without early treatment, the GCA can lead to permanent vision loss, and life-threatening complications, such as aneurysms and stroke.
Osteosarcoma is the most common type of bone cancer affecting children, adolescents, and young adults. This aggressive cancer typically originates in the long bones, such as the femur (thighbone), tibia (shinbone), or humerus (upper arm bone), and can sometimes spread to other areas of the body.
Giant Cell Tumor (Osteoclastoma)
Foreign body giant cells (FBGC) most commonly are observed at the tissue/material interface of implanted medical devices, prostheses, and biomaterials (**2). In this context, adherent macrophages and foreign body giant cells constitute the foreign body reaction (Figure 1).
Symptoms
Giant cell tumors are aggressive and fast-growing. Even though they aren't life-threatening, they can cause pain and damage by destroying nearby healthy bones. Typical places for a giant cell tumor of bone to grow include: Hip, at the upper end of the thighbone.
Doctors don't have a way to know when your cancer first started, which means they can't know how long it took to get to the size it is now. It could have been weeks, months, or longer.
TURALIO is a prescription medicine used to treat certain adults who have TGCT that is not likely to improve with surgery. TGCT is also known as giant cell tumor of the tendon sheath (GCT-TS) or pigmented villonodular synovitis (PVNS).
Because of chemotherapy's considerable side effects, it may not be safe for individuals who have underlying conditions. If your oncologist worries that your body is not strong enough to withstand chemotherapy, they will likely recommend other treatment options.
The six least survivable cancers are aggressive and often diagnosed late. These include pancreatic, liver, esophageal, lung, stomach, and brain cancers. They grow fast and are hard to treat. Knowing what they have in common helps us find better ways to fight them.
Primary tumors are those located at the site where the tumor began to grow (i.e., where it originated). Metastatic (or Secondary) tumors are those that have spread to other parts of body from the original tumor site. Tumors are also classified based on their tendency to grow.
GCA follows a polygenic inheritance pattern and rare familiar clustering. [1-6] Thomsen et al. [7] reported a study in which only 1% of observed individuals diagnosed with GCA had a first-degree relative with GCA.
Generally a minimum of one week off from work is necessary. If the patient can return to work while wearing a cast and they are allowed to perform light duty they may be able to return to work after one week. The surgery is generally successful and without complications.
Our study shows that benign giant-cell tumor of bone can produce pulmonary metastases, that metastases most often occurred with recurrent local disease and distal radial lesions, that the prognosis was relatively favorable, and that such metastases had no distinguishing radiologic features.